PanTher Therapeutics, Inc. — Form D

PanTher Therapeutics, Inc. of Austin, TX, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-18. The offering totals $5.0M, of which $2.7M was reported sold. Industry: Biotechnology.

Offering

Filed: 2023-12-18
Form: D
Accession: 0001644045-23-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $5.0M
Amount sold: $2.7M
Remaining: $2.3M
Investors: 28
Date of first sale: 2023-11-30
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-499925

Issuer

Name: PanTher Therapeutics, Inc.
CIK: 0001644045
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2014
Address: 7000 Bee Caves Road, Austin, TX, 78746
Phone: 8574131698

Officers, directors & promoters (10)

Name	Role	Location
Manish Bhandari	Director	Austin, TX
John Edwards	Director	Atlanta, GA
Darshana Zaveri	Director	BEDFORD, MA
Laura Indolfi	Director	Austin, TX
Laura Indolfi	Executive Officer	Austin, TX
D Mackey	Director	Austin, TX
Daniel Wildman	Director	Austin, TX
Maria Palasis	Director	Austin, TX
David Ting	Director	Chicago, IL
ELAZER EDELMAN	Director	DRAPER, UT

Other filings by this issuer (9)

Filed	Form	Offering	Sold
2025-04-03	D	$5.0M	$3.0M
2022-12-19	D	$2.0M	$1.3M
2022-06-24	D	$1.2M	$1.1M
2021-06-02	D/A	$7.3M	$7.3M
2020-06-04	D	$7.0M	$3.0M
2020-05-18	D	$209K	$209K
2020-05-14	D	$268K	$268K
2016-11-10	D	$500K	$35K
2015-06-08	D	$500K	$95K

More